Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats

Food and Chemical Toxicology

Volumn 48, Issue 1, 2010, Pages 436-440

  Mohan, Mahalaxmi ^a   Kamble, Sarika ^a   Gadhi, Prakash ^b   Kasture, Sanjay ^c  

^a MGV's Pharmacy College   (India)

^b Clinipath Computerised Laboratory   (India)

^c Pinnacle Biomedical Research Institute   (India)

Author keywords

Anti oxidant defence enzyme; Doxorubicin; Marker enzymes; S. torvum

Indexed keywords

CATALASE; CREATININE; DOXORUBICIN; PLANT EXTRACT; SOLANUM TORVUM EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SOLANUM; SOLANUM TORVUM; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLOOD UREA NITROGEN; CATALASE; CREATININE; DOXORUBICIN; FEMALE; KIDNEY; KIDNEY DISEASES; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; SOLANUM; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS; SOLANUM TORVUM;

EID: 72449128132     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.10.042     Document Type: Article

References (44)

1. Adjanohoun, J.E., Aboubakar, N., Dramane, K., Ebot, M.E., Ekpere, J.A., Enoworock, E.G., Foncho, D., Gbile, Z.O., Kamanyi, A., Kamoukom Jr., Keeta, A., Mbenkum, T., Mbi, C.M., Mbielle, A.L., Mbome, I.L., Mubiru, N.K., Naney, W.L., Nkongmeneck, B., Satabie, B., Sofowa, A., Tanze, V., Wirmum, C.K., 1996. Traditional medicine and pharmacopeia-contribution to ethnobotanical and floristic studies in Cameroon. In: CNPMS. Porto-Novo, Benin, pp. 50-52.
2. Ajaiyeoba E.O. Comparative phytochemical and antimicrobial studies of Solanum macrocarpum and Solanum torvum leaves. Fitoterapia 70 (1999) 184-186
3. Ajith T.A., Aswathy M.S., and Hema U. Protective effect of Zingiber officinale roscoe against anti-cancer drug doxorubicin-induced acute nephrotoxicity. Food Chem. Toxicol. 46 (2008) 3178-3181
4. Al-Habri M.M., Al-Gharably N.M., Al-Shabanah O.A., Al-Bekairi A.M., Osman A.M., and Tawfik H.N. Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine. Cancer Chemother. Pharmacol. 31 (1992) 200-204
5. Al-Nasser I.A. In vivo prevention of adriamycin cardiotoxicity by cyclosporin A or FK506. Toxicology 131 (1998) 175-181
6. Arthan D., Svasti J., Kittakoop P., Pittayakhachonwut D., Tanticharoen M., and Thebtaranonth Y. Antiviral isoflavonoid sulfate and steroidal glycosides from the fruits of Solanum torvum. Phytochemistry 59 (2002) 459-463
7. Arthan D., Kittakoop P., Esen A., and Svasti J. Furostanol glycoside 26-O-β glucosidase from the leaves of Solanum torvum. Phytochemistry 67 (2006) 27-33
8. Bachur N.R., Gordon S.L., Gee M.V., and Kon H. NADPH-cytochrome P450 reductase activation of quinone anticancer agents to free radicals. Proc. Natl. Acad. Sci. USA 76 (1979) 954-957
9. Beers R.F.J.R., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 115 (1952) 133-140
10. Blum R.H., and Carter S.K. A new drug with significant clinical activity. Ann. Intern. Med. 80 (1974) 249-256
11. Calabresi P., and Chabner B.A. Chemotherapy of neoplastic diseases. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). The Pharmacological Basis of Therapeutics (1990), Pergamon Press Inc., NY 1203-1263
12. Carabot C.A., Blunden G., and Patel V.A. Chlorogenone and neochlorogenone from the Unripe fruits of Solanum torvum. Phytochemistry 30 (1991) 1339-1341
13. Chabner B.A., Ryan D.P., Paz-Ares L., Garcia-Carbonevo R., and Calabresi P. Antineoplastic agents. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics (2001), McGraw-Hill Companies Inc., USA 1389-1459
14. Chah K.F., Muko K.N., and Oboegbulem S.I. Antimicrobial activity of methanolic extract of Solanum torvum fruit. Fitoterapia 71 (2000) 187-189
15. Chen A., Sheu L.F., Ho Y.S., Lin Y.F., Chou W.Y., Chou T.C., and Lee W.H. Experimental focal segmental glomerulosclerosis in mice. Nephron 78 (1998) 440-452
16. Deman A., Ceyssens B., Pauwels M., Zhang J., Houte Verbeelen K.V., et al. Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis. Nephrol. Dial. Transplant. 16 1 (2001) 147-150
17. Fadilloglue E., Oztas E., Erdogan H., Yagmurca M., Sogut S., Ucar M., and Irmac M.K. Protective effect of caffeic acid phenyl ethyl ester of doxorubicin induced nephrotoxicity in rats. J. Appl. Toxicol. 24 (2004) 47-52
18. Gillick J., Giles S., Bannigan J., and Puri P. Cell death in the early adriamycin rat model. Pediatr. Surg. Int. 18 (2002) 576-580
19. Haenen G.R.M.M., Janssen F.P., and Bast A. The antioxidant properties of five (O-β hydroxyethyl) rutosides of the flavonoid mixture Venoruton. Phlebol. Suppl. 1 (1993) 10-17
20. Iida Y., Yanai Y., Ono M., Ikeda T., and Nohara T. Three unusual 22-β-O-23-hydroxy-(5α)-spirostanol glycosides from the fruits of Solanum torvum. Chem. Pharm. Bull. 53 (2005) 1122-1125
21. Israf D.A., Lajis N.H., Somchit M.N., and Sulaiman M.R. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract. Life Sci. 75 (2004) 397-406
22. Kokate C.K. Practical Pharmacognosy. third ed. (1994), Vallabh Prakashan, New Delhi 107-109
23. Lee V., Randhawa A.K., and Singhal P.K. Adriamycin induced myocardial dysfunction in vitro is mediated by free radicals. Am. J. Physiol. 261 (1991) H989-H995
24. Mahmood U., Shukla Y.N., and Thakur R.S. Non-alkaloidal constituents from Solanum torvum leaves. Phytochemistry 22 (1983) 167-170
25. Mahmood U., Agrawal P.K., and Thakur R.S. Torvonin-A, a spirostane Saponin from Solanum torvum leaves. Phytochemistry 24 (1985) 2456-2457
26. Misra H.P., and Fridovich I. The generation superoxide radical during the autooxidation of hemoglobin. J. Biol. Chem. 247 (1972) 6960-6962
27. Ndebia E.J., Kamga R., and Nchunga-Anye Nkeh B. Analgesic and anti-inflammatory properties of aqueous extract from leaves of Solanum torvum (Solanaceae). AJTCAM 4 (2007) 240-244
28. Nguelefack T.B., Feumebo C.B., Watcho G.A.P., Tatsimo S., Atsamo A.D., Tane P., Kamanyi A., et al. Anti-ulcerogenic properties of the aqueous and methanol extracts from the leaves of Solanum torvum Swartz (Solanaceae) in rats. J. Ethnopharmacol. 119 1 (2008) 135-140
29. Nguelefack T.B., Mekhfi H., Dimo T., Afkir S., Nguelefack-Mbuyo E.P., Legssyer A., and Ziyyat A. Cardiovascular and anti-platelet aggregation activities of extracts from Solanum torvum (Solanaceae) fruits in rat. J. Comput. Int. Med. 5 1 (2008) 1-11
30. Pritsos C.A., and Ma J. Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity. Chem. Biol. Interact. 127 (2000) 1-11
31. Saad S.Y., Najjar T.A., and Al-Rykaby A.C. The preventive role of deferoxamine against acute doxorubicin-s induced kidney, renal and hepatotoxicity in rats. Pharmacol. Res. 43 (2001) 211-218
32. Saggu H., Cooksey J., and Dexter D.A. Selective increase in particulate Superoxide dismutase activity in Parkinsonian subtansia nigra. J. Neurochem. 53 (1989) 692-697
33. Shah S. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 35 (1989) 1093-1106
34. Siemonsma, J.S., Piluek, K., 1994. Plant Resources of South-East Asia 8 (PROSEA). Bogor, Indonesia.
35. Singal P.K., Li T., Kumar D., Danelisen I., and Hiskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol. Cell. Biochem. 207 (2000) 77-86
36. Sivapriya M., and Srinivas L. Isolation and purification of a novelantioxidant protein from the water extract of Sundakai (Solanum torvum) seeds. Food Chem. 104 (2007) 510-517
37. Slinkard K., and Singleton V.L. Total phenol analyses: automation and comparison with manual methods. Am. J. Enol. Vitic. 8 (1977) 49-55
38. Tallaj J.A., Veronica F., Rayburn B.K., Pinderski L., Benza R.L., Pamboukian S., Foley B., and Bourge R.C. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure. J. Heart Lung Transplant. 24 (2005) 2196-2200
39. Vaclavi{dotless}kova R., Kondrova E., Ehrlichova D.M., Boumendjel A., Kovar J., Stopka P., et al. The effect of flavonoid derivatives on doxorubicin transport and metabolism. Bioorg. Med. Chem. 16 (2008) 2034-2042
40. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharmacol. 124 (1998) 425-427
41. Woisky R., and Salatino A. Analysis of propolis: some parameters and procedures for chemical quality control. J. Agric. Res. 37 (1998) 99-105
42. Yagmurca M., Erdogan H., Iraz M., Songur A., Ucar M., and Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin. Chim. Acta 348 (2004) 27-34
43. Yahara S., Yamashita T., Nozawa N., and Nohara T. Steroidal glycosides from Solanum torvum. Phytochemistry 43 (1996) 1069-1074
44. Yilmaz S., Atessahin A., Sahna E., Karahan I., and Ozer S. Protective effect of lycopene on adriamycin-induced nephrotoxicity and nephrotoxicity. Toxicology 218 (2006) 164-171